Although RBANS Update was originally developed with a primary focus on assessment of dementia, special group studies are available for Alzheimer’s Disease, Vascular Dementia, HIV Dementia, Huntington’s Disease, Parkinson’s Disease, Depression, Schizophrenia, and Closed Head Injury. RBANS also has utility as a screener for neurocognitive status in younger patients.
Benefits
- Covers five domains: Immediate Memory, Visuospatial/Constructional, Language, Attention, and Delayed Memory.
- Screen for deficits in acute-care setting and neurocognitive status in adolescents.
- Track recovery during rehabilitation and progression of neurological disorders.
- Use as a stand-alone “core” battery for the detection and characterization of dementia in the elderly
- Use as a neuropsychological “screen battery” when lengthier standardization assessments are either impractical or inappropriate
- Repeat evaluations when an alternate form is needed to control for content practice effects.
- Identify inclusion/exclusion criteria as well as efficacy and cognitive side effects in Clinical Trials.
Features
RBANS Update provides significant improvements and is ideal for measuring change over time. It can serve as a neuropsychological “screen battery” when lengthier standardization assessments are either impractical or inappropriate.
- Downward age extended to 12:0 years.
- Four parallel forms: Form A offers a single set of norms based on age, gender, race, education, and geographic region, with equating studies and adjustments for Forms B-D and Spanish Form A.
- Subtest scores now available in addition to index scores.
- Manual updated, including new information on adolescents and a review of RBANS-specific research conducted since original publication.